FDA 483 - Sant P. Chawla, MD - April 15, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sant P. Chawla, MD, Clinical Investigator, in Santa Monica, CA, revealed a significant protocol deviation during a human clinical study. The investigator failed to immediately hold a subject's investigational drug despite becoming aware of abnormal laboratory results, leading to the subject continuing the drug for several days and subsequently being hospitalized with serious conditions. This indicates a critical failure in patient safety and adherence to the investigational plan.
ID · 0a32a8a1-6d5e-481b-917d-19be4066a625